Grantham, Mayo, Van Otterloo & Co (GMO)’s Exelixis EXEL Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.64M	Sell	38,235 -30,223	-44%	-$1.3M	﹤0.01%	455
2025 Q4	$3M	Buy	68,458 +56,609	+478%	+$2.34M	0.01%	373
2025 Q3	$489K	Buy	+11,849	New	+$476K	﹤0.01%	528
2025 Q1	–	Sell	-151,153	Closed	-$5.03M	–	641
2024 Q4	$5.03M	Buy	151,153 +67,256	+80%	+$2.18M	0.02%	302
2024 Q3	$2.18M	Buy	+83,897	New	+$2.09M	0.01%	366
2023 Q1	–	Sell	-97,100	Closed	-$1.56M	–	720
2022 Q4	$1.56M	Buy	97,100 +75,200	+343%	+$1.23M	0.01%	464
2022 Q3	$343K	Buy	21,900 +3,800	+21%	+$73.4K	﹤0.01%	614
2022 Q2	$377K	Buy	+18,100	New	+$373K	﹤0.01%	642
2018 Q3	–	Sell	-31,000	Closed	-$667K	–	547
2018 Q2	$667K	Buy	31,000 +4,700	+18%	+$97.2K	﹤0.01%	432
2018 Q1	$583K	Buy	+26,300	New	+$727K	﹤0.01%	462

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s EXEL Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Exelixis (EXEL) stake by 44% in Q1 2026, selling an estimated $1.3M and leaving 38,235 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #455.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in EXEL in Q1 2018 and has held it in 10 quarters since. The position peaked at $5.03M in Q4 2024. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

Grantham, Mayo, Van Otterloo & Co (GMO) held 38,235 shares of Exelixis worth $1.64M as of Q1 2026.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 30,223 Exelixis shares in Q1 2026, an estimated $1.3M.
Exelixis made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #455 holding.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Exelixis in Q1 2018 and has held it in 10 quarters since.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Exelixis position peaked at $5.03M in Q4 2024.
694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.